On ECHEMI
Home > Drugs > Gansu Lanyao Pharmaceutical Co., Ltd.
Gansu Lanyao Pharmaceutical Co., Ltd.
  • Founded in:

    2006-12-22
  • Country:

    China China
  • Address:

    No. 1739, Middle Section of Kunlunshan Avenue, Lanzhou New District, Lanzhou City, Gansu Province
  • Tax NO.:

    916200007948829218
  • Registered Funds:

    84.5 million yuan
  • Email:

Related Drugs
Indomethacin Enteric-coated Tablets
The main ingredients of this product and their chemical names are: The main ingredient of this product is indomethacin, and its chemical name is 2-methyl-1-(4-chlorobenzoyl)-5-methoxy-1H-indole-3-acetic acid.
Name Description Content CAS NO. Registered Holders
Indometacin

This product has anti-inflammatory, antipyretic and analgesic effects. Its mechanism of action is to reduce the synthesis of prostaglandins by inhibiting cyclooxygenase. It stops the formation of pain nerve impulses in inflammatory tissues and inhibits inflammatory reactions, including inhibiting the chemotaxis of leukocytes and the release of lysosomal enzymes. As for the antipyretic effect, it acts on the hypothalamic temperature regulation center, causing peripheral vasodilation and sweating, which increases heat dissipation. This central antipyretic effect may also be related to the inhibition of prostaglandin synthesis in the hypothalamus.

More

This product has anti-inflammatory, antipyretic and analgesic effects. Its mechanism of action is to reduce the synthesis of prostaglandins by inhibiting cyclooxygenase. It stops the formation of pain nerve impulses in inflammatory tissues and inhibits inflammatory reactions, including inhibiting the chemotaxis of leukocytes and the release of lysosomal enzymes. As for the antipyretic effect, it acts on the hypothalamic temperature regulation center, causing peripheral vasodilation and sweating, which increases heat dissipation. This central antipyretic effect may also be related to the inhibition of prostaglandin synthesis in the hypothalamus.

53-86-1 23
Oryzanol Tablets
Oryzanol
Name Description Content CAS NO. Registered Holders
Gamma oryzanol

This product has the function of regulating autonomic nervous system dysfunction and endocrine balance disorders.

More

This product has the function of regulating autonomic nervous system dysfunction and endocrine balance disorders.

11042-64-1 10
Aluminum Hydroxide Tablets
The calculated amount of aluminum hydroxide contained in each tablet of this product shall not be less than 0.135g.
Name Description Content CAS NO. Registered Holders
Aluminum hydroxide

Anti-acid, mucosal protection, local hemostasis, etc., the effect is slow and long-lasting, but the efficacy is weak

More

Anti-acid, mucosal protection, local hemostasis, etc., the effect is slow and long-lasting, but the efficacy is weak

0.135g 21645-51-2 14
Compound aluminum hydroxide tablets
This product is a compound preparation, each tablet contains the main ingredients of aluminum hydroxide 0.245g, magnesium trisilicate 0.105g, belladonna fluid extract 0.0026ml. Auxiliary materials: starch, magnesium stearate.
Name Description Content CAS NO. Registered Holders
Aluminum hydroxide

Anti-acid, mucosal protection, local hemostasis

More

Anti-acid, mucosal protection, local hemostasis

0.245g 21645-51-2 14
Magnesium trisilicate

Anti-acid, mucosal protection, local hemostasis

More

Anti-acid, mucosal protection, local hemostasis

0.105g 14987-04-3 11
Extract Belladonna soft liquid and powder

Anti-acid, mucosal protection, local hemostasis

More

Anti-acid, mucosal protection, local hemostasis

0.0026ml 0
Carbamazepine Tablets
Carbamazepine, its chemical name is: 5H-dibenzo[b,f]azepine-5-carboxamide
Name Description Content CAS NO. Registered Holders
Carbamazepine

Anticonvulsant, anti-epileptic, anti-neuropathic pain, anti-manic-depressive, improve symptoms of certain mental illnesses, anti-central diabetes insipidus. The mechanism may include: 1. Use-dependent blocking of various excitable cell membrane Na channels, inhibiting the occurrence and spread of abnormal high-frequency discharges; 2. Inhibition of T-type calcium channels; 3. Enhancement of the activity of central noradrenergic nerves; 4. Promoting the secretion of antidiuretic hormone (ADH) or increasing the sensitivity of effectors to ADH.

More

Anticonvulsant, anti-epileptic, anti-neuropathic pain, anti-manic-depressive, improve symptoms of certain mental illnesses, anti-central diabetes insipidus. The mechanism may include: 1. Use-dependent blocking of various excitable cell membrane Na channels, inhibiting the occurrence and spread of abnormal high-frequency discharges; 2. Inhibition of T-type calcium channels; 3. Enhancement of the activity of central noradrenergic nerves; 4. Promoting the secretion of antidiuretic hormone (ADH) or increasing the sensitivity of effectors to ADH.

298-46-4 42
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.